Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Annotation

Citrome L. Interpreting and applying the EUFEST results using number needed to treat: antipsychotic effectiveness in first-episode schizophrenia. Int J Clin Pract . 2008 May ; 62(5):837-40. PubMed Abstract

Comments on Related News
Related News: Study Questions Advantages of Newer Antipsychotics for Early Schizophrenia

Comment by:  Jan Volavka
Submitted 2 April 2008 Posted 3 April 2008
  I recommend the Primary Papers

The EUFEST study found that haloperidol, in comparison...  Read more


View all comments by Jan Volavka

Related News: Study Questions Advantages of Newer Antipsychotics for Early Schizophrenia

Comment by:  Peter F. Buckley
Submitted 11 April 2008 Posted 11 April 2008

This timely study, conducted by a stellar group of...  Read more


View all comments by Peter F. Buckley

Related News: Study Questions Advantages of Newer Antipsychotics for Early Schizophrenia

Comment by:  Leslie Citrome
Submitted 18 April 2008 Posted 19 April 2008
  I recommend the Primary Papers

Although in EUFEST, psychopathology improved to a similar...  Read more


View all comments by Leslie Citrome

Related News: Study Questions Advantages of Newer Antipsychotics for Early Schizophrenia

Comment by:  Herbert Meltzer (Disclosure)
Submitted 29 April 2008 Posted 29 April 2008

EUFEST, CATIE, and CUtLASS: Should Atypical...  Read more


View all comments by Herbert Meltzer

Related News: Study Questions Advantages of Newer Antipsychotics for Early Schizophrenia

Comment by:  Erik JohnsenHugo A. Jorgensen
Submitted 12 May 2008 Posted 14 May 2008

In our recently published systematic review of randomized...  Read more


View all comments by Erik Johnsen
View all comments by Hugo A. Jorgensen
Submit a Comment on this Paper
Make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Affiliation  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
 
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend this paper

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


 
 
SRF News
SRF Comments
Text Size
Reset Text Size
Share/Bookmark
 
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright